LoginSignup
AMP

Amphastar Pharms

Stock
Stock
ISIN: US03209R1032
Ticker: AMPH
US03209R1032
AMPH

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 

$0.30

CHART BY

Frequently asked questions

What is Amphastar Pharms's market capitalization?

The market capitalization of Amphastar Pharms is $1.88B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Amphastar Pharms's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Amphastar Pharms is 13.02. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Amphastar Pharms?

Amphastar Pharms's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.005. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Amphastar Pharms's stock?

Currently, 6 analysts cover Amphastar Pharms's stock, with a consensus target price of $58.20. Analyst ratings provide insights into the stock's expected performance.

What is Amphastar Pharms's revenue over the trailing twelve months?

Over the trailing twelve months, Amphastar Pharms reported a revenue of $723.55M.

What is the EBITDA for Amphastar Pharms?

Amphastar Pharms's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $270.59M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Amphastar Pharms?

Amphastar Pharms has a free cash flow of $170.15M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Amphastar Pharms have, and what sector and industry does it belong to?

Amphastar Pharms employs approximately 1,761 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.

What is the free float of Amphastar Pharms's shares?

The free float of Amphastar Pharms is 35.79M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$1.88B
EPS (TTM) 
$3.005
Free Float 
35.79M
P/E ratio (TTM) 
13.02
Revenue (TTM) 
$723.55M
EBITDA (TTM) 
$270.59M
Free Cashflow (TTM) 
$170.15M

Pricing

1D span
$39.13$39.34
52W span
$36.58$65.59

Analyst Ratings

The price target is $58.20 and the stock is covered by 6 analysts.

Buy

4

Hold

2

Sell

0

Information

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Employees
1,761
Industries
Pharmaceuticals: Major
Sector
Health Care

Identifier

ISIN
US03209R1032
Primary Ticker
AMPH

Knockouts

Join the conversation
Sign upLogin